Christopher Ogden - Mar 19, 2024 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
SVP, Finance and Accounting
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Christopher Ogden
Stock symbol
CTMX
Transactions as of
Mar 19, 2024
Transactions value $
-$6,196
Form type
4
Date filed
3/21/2024, 04:38 PM
Previous filing
Jan 19, 2024
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$6.2K -2.97K -3.35% $2.09 85.7K Mar 19, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 60,310 restricted stock units.